MoneyWorks4Me

The revenue for the June 2026 quarter is pegged at Rs. 822.32 millions, about 8.76% up against Rs. 756.12 millions recorded during the year-ago period.A humble growth in net profit of 22.18% reported in the quarter ended June 2026 to Rs. 131.89  millions from Rs. 107.95 millions.The company reported a good operating profit of 200.73 millions compared to 170.38 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 822.32 756.12 8.76 822.32 756.12 8.76 2872.25 2687.16 6.89
Other Income 28.33 28.25 0.28 28.33 28.25 0.28 119.95 81.90 46.46
PBIDT 200.73 170.38 17.81 200.73 170.38 17.81 700.69 592.61 18.24
Interest 2.51 2.54 -1.18 2.51 2.54 -1.18 10.28 9.58 7.31
PBDT 198.22 167.84 18.10 198.22 167.84 18.10 669.62 779.90 -14.14
Depreciation 21.42 23.53 -8.97 21.42 23.53 -8.97 94.44 81.31 16.15
PBT 176.80 144.31 22.51 176.80 144.31 22.51 575.18 698.59 -17.67
TAX 44.91 36.36 23.51 44.91 36.36 23.51 144.36 144.98 -0.43
Deferred Tax 3.13 4.65 -32.69 3.13 4.65 -32.69 12.49 9.26 34.88
PAT 131.89 107.95 22.18 131.89 107.95 22.18 430.82 553.61 -22.18
Equity 131.68 133.06 -1.04 131.68 133.06 -1.04 133.93 132.80 0.85
PBIDTM(%) 24.41 22.53 8.33 24.41 22.53 8.33 24.40 22.05 10.62
Peers
Company Name CMP
Sun Pharma. Inds. 1846.35
Dr. Reddys Labs. 1219.15
Cipla 1384.95
Lupin 2058.40
Zydus Lifesciences 1209.75
View more..